FilingSEC EDGAR6-K
Cellyan Biotechnology Announces Change in Independent Director
· SEC accepted
StageBoard Composition Change
Filing content
The company announced the resignation of independent director Mike Yao Zhou and the appointment of Letao Zhao as his successor, effective September 18, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…